These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17997165)

  • 1. Two new scales of formal thought disorder in schizophrenia.
    Barrera A; McKenna PJ; Berrios GE
    Psychiatry Res; 2008 Jan; 157(1-3):225-34. PubMed ID: 17997165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formal thought disorder, neuropsychology and insight in schizophrenia.
    Barrera A; McKenna PJ; Berrios GE
    Psychopathology; 2009; 42(4):264-9. PubMed ID: 19521143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thought disorder in schizophrenia is associated with both executive dysfunction and circumscribed impairments in semantic function.
    Stirling J; Hellewell J; Blakey A; Deakin W
    Psychol Med; 2006 Apr; 36(4):475-84. PubMed ID: 16403241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairments associated with formal thought disorder in people with schizophrenia.
    Kerns JG; Berenbaum H
    J Abnorm Psychol; 2002 May; 111(2):211-24. PubMed ID: 12003444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of formal thought disorder: The relation between the Kiddie Formal Thought Disorder Rating Scale and clinical judgment.
    de Bruin EI; Verheij F; Wiegman T; Ferdinand RF
    Psychiatry Res; 2007 Jan; 149(1-3):239-46. PubMed ID: 17156854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizotypal traits impact upon executive working memory and aspects of IQ.
    Matheson S; Langdon R
    Psychiatry Res; 2008 May; 159(1-2):207-14. PubMed ID: 18423612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alogia and formal thought disorder: differential patterns of verbal fluency task performance.
    Docherty AR; Berenbaum H; Kerns JG
    J Psychiatr Res; 2011 Oct; 45(10):1352-7. PubMed ID: 21555136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring cognitive complaints in schizophrenia: the subjective scale to investigate cognition in schizophrenia.
    Stip E; Caron J; Renaud S; Pampoulova T; Lecomte Y
    Compr Psychiatry; 2003; 44(4):331-40. PubMed ID: 12923712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Neuropsychological Correlates in Positive and Negative Formal Thought Disorder Syndromes: The Thought and Language Disorder Scale in Endogenous Psychoses.
    Nagels A; Fährmann P; Stratmann M; Ghazi S; Schales C; Frauenheim M; Turner L; Hornig T; Katzev M; Müller-Isberner R; Grosvald M; Krug A; Kircher T
    Neuropsychobiology; 2016; 73(3):139-47. PubMed ID: 27058747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confabulation in schizophrenia and its relationship to clinical and neuropsychological features of the disorder.
    Lorente-Rovira E; Pomarol-Clotet E; McCarthy RA; Berrios GE; McKenna PJ
    Psychol Med; 2007 Oct; 37(10):1403-12. PubMed ID: 17506924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation sensitivity as a moderator of communication disorder in schizophrenia.
    Grant PM; Beck AT
    Psychol Med; 2009 Jul; 39(7):1211-9. PubMed ID: 19379529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Context representation and thought disorder in schizophrenia.
    Roesch-Ely D; Spitzer M; Kaiser S; Weisbrod M; Pfueller U
    Psychopathology; 2010; 43(5):275-84. PubMed ID: 20639687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thought Disorder Index: a longitudinal study of severity levels and schizophrenia factors.
    Metsänen M; Wahlberg KE; Hakko H; Saarento O; Tienari P
    J Psychiatr Res; 2006 Apr; 40(3):258-66. PubMed ID: 15907939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive substrates in semantic memory of formal thought disorder in schizophrenia.
    Soriano MF; Jiménez JF; Román P; Bajo MT
    J Clin Exp Neuropsychol; 2008 Jan; 30(1):70-82. PubMed ID: 17852594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Barcelona Test for cognitive assessment of patients with schizophrenia.
    Gil D; Bengochea R; Arrieta M; Lastra I; Sánchez R; Alvarez A; Diego M; Prat R
    Actas Esp Psiquiatr; 2008; 36(6):337-44. PubMed ID: 18781409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
    Savilla K; Kettler L; Galletly C
    Aust N Z J Psychiatry; 2008 Jun; 42(6):496-504. PubMed ID: 18465376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehension of metaphor and irony in schizophrenia during remission: the role of theory of mind and IQ.
    Mo S; Su Y; Chan RC; Liu J
    Psychiatry Res; 2008 Jan; 157(1-3):21-9. PubMed ID: 17854910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased positive thought disorder with illness duration in patients with schizophrenia.
    Maeda K; Kasai K; Uetsuki M; Hata A; Araki T; Rogers MA; Yamasue H; Iwanami A
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):687-90. PubMed ID: 18081634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.